Subscribe
Facebook Twitter Instagram Youtube

World Hepatitis Day 2022 Webinar series

28 July, 2022

Webinar one: I Can’t Wait Community Forum

In this forum we hear from people around the globe discussing their experiences of living with hepatitis and why we can’t wait for hepatitis elimination.

The panel taps into the global conversation around eliminating hepatitis by 2030 and offers an open forum for those living with hepatitis.

The panel was chaired by WHA President, Danjuma Adda.

Panelists include:

  • David Urick, hepatitis B patient advocate, living with hepatitis B, working as a patient care manager.
  • Luís Mendão, living with HIV and hepatitis C, currently Chairman of the Board of GAT – Treatment Activists Group.
  • Lien Tran, researcher at the WHO Collaborating Centre for Viral Hepatitis, Doherty Institute.
  • Silvana Lesidrenska, co-founder of the Hepactive Association in 2009 and current chairman, living with hepatitis B.
  • Dee Lee, director and founder of Inno Community Development Organisation

This World Hepatitis Day Community Forum is sponsored by AbbVie.

Webinar two: Mothers & babies can’t wait – fighting mother-to-child transmission

This discussion launched the WHA’s whitepaper on PMTCT which outlines the human impact of mother-to-child transmission and includes policy recommendations.

The panel was chaired by Dr Su Wang, Medical Director, Center for Asian Health & Viral Hepatitis Programs at Cooperman Barnabas Medical Center-RWJBarnabas Health, Past-President World Hepatitis Alliance

Panelists include:

  • Dr Olufunmilayo Lesi, Viral Hepatitis Team Lead, Global HIV, Hepatitis and STIs Programmes World Health Organization
  • Dr Giuseppe Indolfi, Professor of paediatrics, University of Florence
  • Nafisa Yussf, Social Researcher and Project Manager at the WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute
  • Bisi Bright, Consultant Clinical Pharmacist, Lecturer and Public Health Manager; Vice Chairman and CEO of LiveWell Initiative
  • Marinela Debu, President of the Romanian Liver Patients Association (APAH-RO), advocates for patients’ rights, and mother of two 

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close